Authors: Nagata, Y Takata, J Karube, Y Matsushima, Y

Citation: Y. Nagata et al., Effects of a water-soluble prodrug of vitamin E on doxorubicin-induced toxicity in mice, BIOL PHAR B, 22(7), 1999, pp. 698-702

Authors: Takata, J Karube, Y Hanada, M Matsunaga, K Iwasaki, H

Citation: J. Takata et al., Prodrug for bioreductive activation-independent delivery of menahydroquinone-4: Human liver enzymatic activation and its action in warfarin-poisoned human liver, BIOL PHAR B, 22(2), 1999, pp. 172-178

Authors: Takata, J Karube, Y Matsunaga, K Hanada, M Hidaka, R Matsushima, Y

Citation: J. Takata et al., Prodrugs for systemic bioreductive activation-independent delivery of phyllohydroquinone, an active form of phylloquinone (Vitamin K-1) 1: Preparation and in vitro evaluation, BIOL PHAR B, 22(12), 1999, pp. 1347-1354

Authors: Karube, Y Katsuno, K Ito, S Matsunaga, K Takata, J Kuroki, M Murakami, M Matsuoka, Y

Citation: Y. Karube et al., Tumor scintigraphy by the method for subtracting the initial image with technetium-99m labeled antibody, ANN NUCL M, 13(6), 1999, pp. 407-413

Authors: Karube, Y Iwamoto, K Takata, J

Citation: Y. Karube et al., Technetium-99m complex of N-(2-pyridylmethyl)iminodiacetic acid as a new renal radiopharmaceutical, ANN NUCL M, 13(2), 1999, pp. 127-132

Authors: Yoda, R Karube, Y Takata, J Nagata, Y Matsushima, Y

Citation: R. Yoda et al., Technetium-99m complexes with steroid-2-aminooxyethyliminodiacetic acid conjugates, CHEM PHARM, 47(3), 1999, pp. 413-416